Video & Transcript Research : 'drug access'
Page 1 of 500
US
US Federal 2025-2026 Regular Session
Business meeting to consider S.527, to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, S.1040, to amend the Federal Trade Commis Apr 3rd, 2025 at 09:15 am
Senate Judiciary
Transcript Highlights:
- They'll help make prescription drugs more affordable.
- Hopefully, transparency driving down the cost of prescription drugs.
- The fact is drug prices are too high.
- The Drug Competition Enforcement Act would prohibit product hopping.
- drug dealer. manufacturer from offering patients a far more affordable generic version of the drug.
Keywords:
drug competition, product hopping, generic drugs, biosimilars, federal regulations, FTC Act, patent, biological products, healthcare access, affordable prescriptions, Medicare, Federal Trade Commission, sham petitions, competition, public health, unfair competition, healthcare, pharmaceutical, antitrust law, pay-for-delay
Summary:
The meeting focused on addressing the high cost of prescription drugs and the abusive practices that contribute to elevated prices affecting American families. Several bills were presented, including proposals to end pay-for-delay deals and to enhance transparency in the operations of pharmacy benefit managers (PBMs). The discussion was notable for its emphasis on consumer protection and ensuring that cheaper generic drugs reach the market more effectively. Members expressed frustration over past attempts to pass similar legislation stalling in the Senate, leading to renewed efforts to push these bills forward.
TX
Keywords:
healthcare, training, abuse, neglect, penalties, chemical dependency, safety, regulation, newborn screening, Duchenne muscular dystrophy, heritable diseases, public health, early detection, mental health, telemedicine, physical examination, healthcare access, inpatient facility, pharmaceuticals, Texas Pharmaceutical Initiative
TX
Keywords:
healthcare, training, abuse, neglect, penalties, chemical dependency, safety, regulation, newborn screening, Duchenne muscular dystrophy, heritable diseases, public health, early detection, mental health, telemedicine, physical examination, healthcare access, inpatient facility, pharmaceuticals, Texas Pharmaceutical Initiative
AL
Alabama 2025 Regular Session
Alabama Senate Children and Youth Health Committee Feb 12th, 2025
Children and Youth Health
Transcript Highlights:
- As a mother, when my three children became teenagers, I desperately wanted my children to have access
- the permission of the abuser, and that abusive parents have… abuser, and that abusive parents have access
- There is a risk that children living with grandparents or other kin would not be able to access services
- I can see where 14 is a pretty young age for medical consent or having access to medical care.
- Or... ...whatever with a 14, 15, 16, 17-year-old getting access to medical care.
Keywords:
parental rights, minor consent, medical consent, mental health services, school counseling, student counseling, parental notification, opt-in, health records, HIPAA, vaccine consent, adolescent health, youth privacy, confidential counseling, school mental health, reproductive health, pregnancy services, sexually transmitted infections, STI treatment, substance abuse treatment
FL
Florida 2026 Regular Session
Children, Families, and Elder Affairs Jan 27th, 2026
Children, Families, and Elder Affairs
Transcript Highlights:
- And as DRF, we would like a wider swath of individuals to be able to access work.
- Unfortunately, what that means is we lose access to our in-home care and I lose access to the waiver,
- and my job is in jeopardy. ...access to our in-home care, and I lose access to the waiver, and my job
- to be able to achieve their dreams... ...that is on a home and community-based waiver has access to
- Senate Bill 1594 would ensure that veterans' benefits accessed by a foster care agency are not used to
Keywords:
child welfare, substance abuse, neglect, parental rights, drug exposure, Medicaid, disabilities, employment, healthcare access, income eligibility, veteran benefits, minor clients, financial assistance, education services, Department of Children and Families, Department of Health, aging services, disability assistance, long-term care, Alzheimer's support
Summary:
The committee considered several bills affecting children, disability services, aging, recovery residences, and foster youth benefits. SB 1016 codified the working people with disabilities program for Medicaid waiver recipients, with amendments removing automatic enrollment and improving information sharing between agencies; advocates testified that the program helps people with developmental disabilities work while keeping needed care, though they raised implementation and training concerns. The bill was reported favorably. SB 1002, as amended, clarified that evidence of acute or chronic parental drug abuse can constitute harm or neglect in child welfare cases and allow court intervention and treatment requirements; it was also reported favorably. SB 1594 would preserve veterans’ benefits for foster youth for postsecondary education or aftercare rather than using them as reimbursement to the agency, and it passed favorably. SB 1630 modernized aging and long-term care statutes, expanded emergency service authority, updated oversight of area agencies on aging and guardianship, and permanently established the Florida Alzheimer’s Center of Excellence; after two amendments, it was reported favorably. SB 1030, on recovery residences/substance abuse services, was amended with a substitute that narrowed transfer definitions, sped licensure for existing providers adding levels of care, and limited credentialing entities’ access to resident records; members noted it remained a work in progress, but it was reported favorably.
The committee also held confirmation hearings. Robert Astellos, nominated as Director of the Agency for Persons with Disabilities, described efforts to reduce the pre-enrollment list, improve transparency and customer service, expand family involvement, and streamline agency processes; multiple advocacy groups appeared in support, and the committee recommended his confirmation. The committee then unanimously recommended confirmation of the appointees on tabs 7 through 10. The meeting concluded with adjournment.
US
US Federal 2025-2026 Regular Session
Hearings to examine certain pending nominations. Apr 30th, 2025 at 09:15 am
Senate Judiciary
Transcript Highlights:
- They're involved in drugs, fentanyl. Extortion, kidnapping, drugs, intimidation, money laundering.
- I'm claiming that... ...in terms of drug dealing? Sorry to interrupt you, sir.
- How does this diversion of resources help us fight drugs in our communities?
- And so many times violent crime is tied to drug trafficking.
- to Test Strips Act, and the bill would help prevent drug over- doses and deaths by allowing access to
Keywords:
fentanyl crisis, DEA, drug trafficking, public safety, Judea Serrata, Terrence Cole, judicial security, social media, drug prevention
Summary:
The committee meeting centered on the urgent crisis of fentanyl abuse and the government’s response to the drug trafficking epidemic. Key discussions revolved around the nomination of Terrence Cole as the Administrator of the DEA and Judea Serrata as Director of the U.S. Marshals Service. Cole emphasized his commitment to combating the fentanyl crisis, highlighting the rising number of overdose deaths and the necessity of bipartisan efforts to dismantle drug cartels. Members engaged in dialogue on the effectiveness of various strategies and the importance of education aimed at preventing drug-related deaths among youth. Additionally, the challenges of social media in drug trafficking were highlighted, indicating a need for greater accountability in how platforms handle such issues. Senators voiced concerns about the impact of administration policies on judicial security and the resources available for marshals to perform their critical roles.
LA
Transcript Highlights:
- The drug price we use is the same drug price that the federal government has released.
- on generic drugs.
- that drug.
- acquire that drug.
- If we have access to the drug, that doesn't mean that we will be paid fairly for it.
Keywords:
automobile repairs, insurance transparency, repair shop liability, non-OEM parts, policyholder rights, automobile insurance, appraisal process, insurance policyholders, dispute resolution, claim valuation, family leave, insurance, paid leave, employment benefits, caregiver support, behavioral health, crisis services, mental health care, insurance coverage, healthcare access
US
US Federal 2025-2026 Regular Session
Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nominations of Todd Blanche, of Florida, to be Deputy Attorney General, and Abigail Slater, of the Distr Feb 20th, 2025 at 09:15 am
Senate Judiciary
Transcript Highlights:
- Under Holt-Fentanyl, patients will have the same access.
- It's the deadliest drug in American history.
- The amendment would help prevent drug overdose. 15,000 overdoses and deaths by allowing much needed access
- It's actually used by people who are using drugs to test their drug beforehand.
- Chairman, of wanting to defer to states, but in the area of drug enforcement and drug definition and
Bills:
SB331
Keywords:
fentanyl, controlled substances, drug trafficking, public health, research regulations, law enforcement, S-331, Halt All Lethal Trafficking and Fentanyl Act, fentanyl crisis, public testimony, drug legislation, bipartisan support
Summary:
In this committee meeting, the focus was primarily on S-331, the Halt All Lethal Trafficking and Fentanyl Act, aimed at addressing the fentanyl crisis. The bill's key components include making permanent the class scheduling of fentanyl-related substances, confirming existing sentencing penalties, and easing registration requirements for scientific research on Schedule I substances. Numerous parents shared heartbreaking testimonies about their losses due to fentanyl, which fueled an urgent call to pass the legislation without alterations. The committee members engaged in passionate discussions highlighting the urgency of the situation as overdoses continue to claim American lives.
MN
Transcript Highlights:
- Thank you. and access like this. So I too am behind and access like this.
- funding, access, and process. funding, access, and process.
- This will impact care capacity overall, or access. My second point is access.
- This will impact care capacity overall, or access. My second point is access.
- improving access to care. improving access to care.
Keywords:
residential pools, swimming classes, certification, private business, health safety, health care, prior authorization, managed care, medical assistance, mental health, substance use treatment, chronic conditions, health insurance, insulin, healthcare access, pharmacy regulations, patient assistance, affordable medication, healthcare, pharmacy
Summary:
The committee met at 1:00 p.m., confirmed a quorum, and approved the April 8, 2026 minutes. The first bill heard was House File 4712, which was laid over after the committee adopted a DE2 amendment. Representative Schultz said the bill would create a narrow additional exception to public pool limitations so highly certified swimming instructors could use certain pools for specialized infant, youth, and developmental-disability swim instruction. The only testifier, Tessa Seppelt, described ISR instruction as water-safety and drowning-prevention training for very young children and children with developmental delays, and said access to appropriate facilities is the main barrier. Members raised questions about emergency egress, public safety, and insurance coverage, and the author said he would follow up on those concerns.
The committee then took up House File 4801, a bill by Representative Nadeau aimed at health care program integrity. He said it would align commercial and Medicaid partners to reduce waste, fraud, and abuse by changing prior authorization and retrospective review processes, improving data sharing on suspected fraud, addressing conflicting or duplicative services, allowing managed care organizations to verify provider credentials, and making risk corridors in MCO contracts permanent. The Minnesota Council of Health Plans supported the bill, saying it would help detect fraud and improve coordination, while the Minnesota chapter of the American Academy of Pediatrics opposed it, arguing that expanded prior authorization would delay care, increase physician burden, and harm children with chronic conditions. Members debated patient safety, fraud detection, and whether the bill would undermine recent prior-authorization reforms. The bill was laid over.
House File 3756, a technical update to the insulin safety net program, was also laid over. Representative Backer said the bill clarifies that a hospital-use intravenous insulin product is not part of the program because it is sold only to health care institutions and infused by practitioners, not dispensed to patients for self-use. The Board of Pharmacy testified that the language was drafted to avoid affecting future legitimate uses, and members asked whether the definition could limit new uses if treatments change. The committee then began House File 4860, but the transcript cuts off before the bill’s presentation is completed.
WY
Transcript Highlights:
- distributing methamphetamine or controlled substance and scheduled one or two, which is a narcotic drug
- is a narcotic drug for a person<00:02:21.280>
under <00:02:21.680>18 <00:02:22.160> - ...other drugs, you know, it's being combined with other drugs.
- to, how do we prove that the person who sold the drug knew that there was a fentanyl mixture?
- He may be in court right now drug cases.
Bills:
SF0009
OK
Oklahoma 2026 Regular Session
Health and Human Services Oversight Mar 4th, 2026 at 03:00 pm
Health and Human Services Oversight
Transcript Highlights:
- They're open access. You can access these medical journals. These are the.
- standards, so His job is access.
- It increases costs and decreases access.
- But the hospital Kept all the liability for those drugs.
- Does this allow does does this allow my local pharmacist to Prescribe drugs or deliver drugs that heretofore
Bills:
HB3552, HB2984, HB4124, HB3934, HB3448, HB3131, HB4200, HB4201, HB3011, HB1912, HB3380, HB3881, HB3538, HB3851, HB3907, HB4430, HB4431, HB4457
Keywords:
childcare, differential pricing, Department of Human Services, child care subsidy, licensed providers, emergency legislation, child care, subsidy program, annual report, program integrity, overpayments, ivermectin, over-the-counter medication, pharmacy immunity, healthcare access, FDA approval, prescription, public health, dentistry, licensing
MN
Minnesota 2025-2026 Regular Session
House Health Finance and Policy Committee 3/9/26
Health Finance and Policy
Transcript Highlights:
- They are magnified by isolation and limited access.
- Without that access, I wouldn't be here.
- Nonetheless, without that access, I wouldn't be here.
- Let me straighten alcohol and hard drugs.
- It's not about drugs; it's about medicine.
Keywords:
social work, licensure, employment titles, health occupations, professional standards, medication repository, drug donation, healthcare, Minnesota Statutes, pharmacy, public health, controlled substances, psilocybin, psilocin, psychedelic, psychedelic medicine, hallucinogen, mushrooms, magic mushrooms, therapeutic use
TX
Texas 89th Regular
Senate Committee on Health and Human Services Mar 18th, 2025
Health & Human Services
Transcript Highlights:
- So it would only be granted through proxy access.
- On average, patients are overpaying $7.32 for generic drugs and $13.46 for brand name drugs.
- This bill is an access to care bill.
- For patients and diminishing access to care.
- It doesn't have to comply with the laws of drugs because it's not a drug; it's a military countermeasure
Keywords:
immunization, written informed consent, civil liability, health care provider, vaccine compensation, administrative penalty, health care, licensing, complaint procedure, disciplinary action, law enforcement, pharmacy benefit manager, PBM, gag clause, prescription drug pricing, out-of-pocket cost, cash price, pharmacist, pharmacy, prescription drug benefit
MS
Transcript Highlights:
- We will now call the meeting of the Senate Drug Policy Committee to order.
- So, so these are all Schedule One drugs? >> Correct.
- Senator Fillingane. >> Drug would be available for?
- And so, like these other drugs, they will simply be listed, and those providers could choose based on
- And so, like these other drugs, they will simply be listed, and those providers could choose based on
Summary:
The Senate Drug Policy Committee met to consider two bills. For House Bill 417, which updates the Uniform Controlled Substances Act by adding substances to Schedule I, committee counsel explained that a strike-all was needed because the House version relied on outdated correspondence. Anna Catherine Lambert of the Mississippi State Department of Health said the department updates the language each year by matching Mississippi law to the DEA’s Federal Register, including salts, isomers, and related forms of newly scheduled substances. She noted the additions largely fall into three broad categories, including fentanyl derivatives, phenidates, and tazenes. Senators asked about the number of compounds and the need to list each derivative form. The committee moved to adopt the strike-all and then the title sufficient do pass strike-all, and the bill was reported.
The committee then took up House Bill 563, which would allow Mississippi law to conform automatically if psilocybin is scheduled by the federal government before the next legislative session. The chair described psilocybin as a mushroom-derived compound being studied in clinical trials for treatment-resistant depression, and noted that an email from Veterans Exploring Treatment Options supported the legislation. Members discussed that the bill would prevent delay if federal scheduling occurs and asked about the conditions for which the substance might be used; the response mentioned treatment-resistant depression, traumatic brain injury, substance use disorder, and other mental health indications. Senator Blackmon made a lighthearted comment about possible amendments, but no amendments were adopted. The committee approved the motion for title sufficient to pass, and House Bill 563 was reported.
US
US Federal 2025-2026 Regular Session
Business meeting to consider the nominations of Jayanta Bhattacharya, of California, to be Director of the National Institutes of Health, and Martin Makary, of Virginia, to be Commissioner of Food and Drugs, both of the Department of Health and Human Mar 13th, 2025 at 08:30 am
Health, Education, Labor, and Pensions Committee
Transcript Highlights:
- Moving on to the Food and Drug Administration, they've confirmed, as FDA Commissioner Dr.
- Not only has the federal government not effectively regulated the price of prescription drugs, although
- We have made progress under the Biden administration in terms of negotiating prescription drug prices
- Unfortunately, despite all of the money that we We have spent on the development of prescription drugs
- Drug companies take the money.
Keywords:
public health, nominations, NIH, FDA, drug affordability, transparency, pharmaceutical industry, healthcare accessibility
Summary:
The meeting focused on vital health-related nominations, primarily emphasizing the roles of Dr. Jay Bhattacharya for NIH Director and Dr. Monty McCary for FDA Commissioner. During the discussion, various senators expressed their support and concerns regarding these nominations. Senator Sanders voiced opposition to both candidates, highlighting issues related to drug affordability and public trust in health agencies. He emphasized the need for leaders committed to transparency and addressing the epidemic of high prescription drug prices, advocating for action against pharmaceutical industry greed. Overall, the conversation underscored the critical crossroads in public health leadership amidst ongoing challenges such as trust restoration and healthcare accessibility.
MS
Mississippi 2025 Regular Session
Drug Policy - Room 409, 4 February, 2025; 10:30 A.M.
MS
Mississippi 2025 Regular Session
Drug Policy - Room 409, 30 January, 2025; 4:15 P.M.
MS
Mississippi 2025 Regular Session
Drug Policy - Room 409, 30 January, 2025; 8:30 A.M.
AZ
Transcript Highlights:
- Then the fentanyl, so a drug dealer, so a drug dealer... In creating pills and capsules.
- You get to court and your defense attorney has caused for an analysis of the drug, the alleged drug.
- drug addict.
- And drugs are rampant inside.
- lot of times due to drug use.
Bills:
SB1003, SB1006, SB1029, SB1037, SB1038, SB1039, SB1040, SB1053, SB1057, SB1060, SB1061, SB1068, SB1069
Keywords:
election, canvass, certification, ballot tabulation, write-in candidates, registration, voting procedures, campaign finance, contribution limits, reporting requirements, political action committees, elections, campaign contributions, candidate committees, posthumous provisions, termination process, Arizona Revised Statutes, voting systems, vote tabulation, election security
Summary:
The Judiciary and Elections Committee opened with roll call, member introductions, and a lengthy agenda item on alleged anomalies involving the State Bar of Arizona. The committee heard live testimony from a former attorney who described his disciplinary experience as retaliatory and unfair, and staff read excerpts from affidavits criticizing bar discipline procedures, notice, and due process. Members debated the State Bar’s authority, attorney discipline rules, and whether attorneys can practice while under investigation, with some arguing the bar is unaccountable and others emphasizing the Supreme Court’s oversight and existing disciplinary procedures.
The committee then considered several election-related bills. SB 1037, requiring stricter security measures for vote-recording and tabulating equipment, passed 4-2-1 after members debated claims of election-system vulnerabilities and the cost of added safeguards. SB 1038, which would make cast vote records publicly available quickly after polls close, was amended to require transmission to the Secretary of State within 48 hours after canvass and then passed 4-2-1. SB 1040, expanding public online access to voter registration rolls in read-only form, also passed 4-2-1 after privacy concerns were raised and the sponsor argued for transparency.
The committee next approved SB 1039, allowing attorneys who prevail in discipline matters to seek damages for reputational harm and lost earnings, despite objections that it raised separation-of-powers concerns and testimony about bar discipline procedures. SB 1053, capping Arizona resident concealed-carry permit fees at 10% of the nonresident fee, passed 4-2-1 after supporters framed it as a constitutional-rights and affordability measure and opponents raised public-safety and revenue concerns. SB 1057, requiring ballot paper fraud-countermeasure features, passed 4-2-1 after debate over cost and vendor capability. SB 1060, removing a voting exemption for U.S. citizens who have never resided in the United States, passed 3-2-2 amid concerns about unintended effects on military families. Finally, SB 1061, lowering the fentanyl threshold for enhanced sentencing from 200 grams to 9 grams, drew strong opposition from defense and civil-liberties witnesses who warned it would sweep in users and prescribed medications; the transcript ends during that testimony, before a final action is shown.
US
US Federal 2025-2026 Regular Session
Hearings to examine interdicting illicit drug trafficking, focusing on a view from the front lines. Feb 26th, 2025 at 10:00 am
Commerce, Science, and Transportation Committee
Transcript Highlights:
- My 33-year career in policing has focused on violent crime, addressing the impacts of drugs and drug
- This includes the drug cartels that have inundated the United States with deadly drugs, violent criminals
- Law enforcement working to disrupt drug trafficking networks need access to telecommunications, automated
- In some communities, the focus on drug trafficking is often subordinate to others' drug or to other threats
- Stop the drugs from coming.
Keywords:
Coast Guard, maritime drug enforcement, illegal drugs, fentanyl crisis, legislative reforms, public testimony
Summary:
The meeting of the Senate Committee on Commerce, Science, and Transportation addressed critical issues surrounding maritime drug enforcement and the Coast Guard's role in stopping the influx of illegal drugs. The chairman highlighted the alarming consequences of current policies allowing drugs to cross borders, emphasizing the need for legislative reforms, such as the Coast Guard Reauthorization Act of 2025. There was an intense discussion regarding the operational challenges faced by the Coast Guard, which has recently made significant drug seizures, indicating progress but also revealing gaps that need addressing. Several witnesses, including victims of the drug crisis, shared their compelling testimonies, which underscored the urgency for stricter controls and comprehensive support for law enforcement agencies involved in drug interdiction efforts.